Women are healthcare’s power users yet face diagnostic delays, higher dismissal rates, and AI bias. New innovators aim to ...
Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") candidate, SER-252, for advanced ...
Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...
Oncology Research Program (ORP) today announced new funding for advancing clinical research in metastatic breast cancer (mBC) ...
A major observational study presented at EACVI 2025 found that valvular heart disease is common in patients with prior cancer diagnoses, with 7.2% showing severe disease on echocardiography.
A new class of DBH graduates showcases groundbreaking research and system-level solutions shaping the future of integrated behavioral healthcare. TEMPE, Ariz., Dec. 3, 2025 / PRZen / Cummings Graduate ...